~~<i id='5F2C3AFA1E'><strike id='5F2C3AFA1E'><tt id='5F2C3AFA1E'><pre id='5F2C3AFA1E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：leisure time 2025-08-12 08:29:54 - browse：1611

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： UnitedHealth argues against case alleging wrongful AI care denials

Wikipedia

hotspot

knowledge

hotspot

knowledge

CTbrainofapatientwithtraumaticbraininjuryshowingsubarachnoidhemorrhage.AdobeTraumaticbraininjury,lon

WSS

Study finds gene variants tied to breast cancer risk in Black women

ASCO eve: Let’s set the table for this year's meeting

Addressing health care workers' trauma can help fight burnout

H5N1 virus can be tracked in retail milk, scientists say

Did the public have the right to know Arthur Ashe had AIDS?

Doctor appointment wait times are getting worse

Wikipedia

comprehensive

Wikipedia

Sports medicine is finally prioritizing gender equality

Doctor appointment wait times are getting worse

The high cost of giving birth even with insurance

7 people shot in DC, police say

Continuity nursing helped my family in our darkest PICU moments

H5N1 virus can be tracked in retail milk, scientists say

Jerome Adams on the need for new antivirals for Covid

Listen: More tumult at BIO & coercive care for sickle cell patients

23andMe had bad news about my health. I wish a person had delivered it

Can food be medicine? And other questions about a new push

hotspot

Meta looks to target Twitter with a rival app called Threads

Making the case for fair compensation in clinical trials

Making the case for fair compensation in clinical trials

Listen: Biogen's messy board & Laronde's data problem

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Why is France rioting? What to know about the fatal police shooting of Nahel M

hotspot

knowledge

hotspot

knowledge